UBS Group’s SAB Biotherapeutics, Inc. Warrant SABSW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,633
| Closed | -$122 | – | 9201 |
|
|
2024
Q4 | $122 | Buy |
+1,633
| New | +$122 | ﹤0.01% | 8383 |
|
|
2024
Q3 | – | Sell |
-56
| Closed | -$3 | – | 8700 |
|
|
2024
Q2 | $3 | Buy |
+56
| New | +$3 | ﹤0.01% | 8247 |
|
|
2024
Q1 | – | Sell |
-29,080
| Closed | -$872 | – | 8567 |
|
|
2023
Q4 | $872 | Buy |
+29,080
| New | +$872 | ﹤0.01% | 7273 |
|
|
2023
Q3 | – | Sell |
-100
| Closed | -$10 | – | 8631 |
|
|
2023
Q2 | $10 | Buy |
+100
| New | +$10 | ﹤0.01% | 7651 |
|
|
2022
Q4 | – | Sell |
-5,606
| Closed | – | – | 9767 |
|
|
2022
Q3 | $0 | Buy |
+5,606
| New | – | ﹤0.01% | 9619 |
|
|
2022
Q1 | – | Sell |
-2,888
| Closed | -$5K | – | 9549 |
|
|
2021
Q4 | $5K | Sell |
2,888
-202
| -7% | -$350 | ﹤0.01% | 8291 |
|
|
2021
Q3 | $3K | Buy |
3,090
+939
| +44% | +$912 | ﹤0.01% | 7679 |
|
|
2021
Q2 | $2K | Sell |
2,151
-1,378
| -39% | -$1.28K | ﹤0.01% | 7859 |
|
|
2021
Q1 | $2K | Buy |
+3,529
| New | +$2K | ﹤0.01% | 7594 |
|